首页> 外文期刊>Breast cancer research and treatment. >Sex Ratio Distortion in Offspring of Families with BRCA1 or BRCA2 Mutant Alleles: An Ascertainment Bias Phenomenon?
【24h】

Sex Ratio Distortion in Offspring of Families with BRCA1 or BRCA2 Mutant Alleles: An Ascertainment Bias Phenomenon?

机译:BRCA1或BRCA2突变等位基因家庭的后代性别比例畸变:确定偏向现象吗?

获取原文
获取原文并翻译 | 示例

摘要

Background. There has been controversy regarding whether BRCA1 germline mutations favor female births or whether the sex imbalances observed are attributable to ascertainment bias. Our aims were to compare the sex ratios among offspring of BRCA1-positive, BRCA2-positive, and BRCA-negative families undergoing genetic testing in clinical programs, and to determine whether ascertainment bias is responsible for the observed preponderance of female offspring.Patients and methods. A total of 145 breast and/or ovarian cancer families with mutations in BRCA1 (n = 83) or BRCA2 (n = 62), and 90 families without identifiable mutation were collected for the study from familial cancer clinics in Barcelona, Spain, and Boston, US. Sex ratio was analyzed among all births in the families and offspring of all (tested and obligate) carriers. In order to minimize the effect of family history of cancer, the analysis was also performed among offspring of the most recent generation of mutation-positive carriers who did not have affected children and compared with a control group comprised of the offspring of the most recent adult generation of non-carriers from families with a known mutation.Results. There was a statistically higher proportion of female births in all groups (BRCA1 59% (95% CI = 57-61%), BRCA2 58% (56-61%), and BRCA-negative 59% (56-61%), respectively). The female preponderance persisted in analyses limited to offspring of BRCA1 and BRCA2 carriers (61% (57-65%), and 62% (58-66%), respectively), with no differences between the two mutation groups. In contrast, the excess of female offspring disappeared when ascertainment or recall biases were minimized, 44% (37-52%), and 39% (26-53%) for BRCA1; 51% (44-58%), and 46% (33-60%) for BRCA2.Conclusions. Our findings suggest that there is no asymmetry in birth outcomes among BRCA1 or BRCA2 mutations carriers. Rather ascertainment bias in families participating in genetic testing, or in the family history information they provide is likely to account for excess of femaleoffspring previously reported.
机译:背景。关于BRCA1种系突变是否有利于女性出生或所观察到的性别失衡是否可归因于确定偏见一直存在争议。我们的目的是比较临床计划中接受基因测试的BRCA1阳性,BRCA2阳性和BRCA阴性家庭的后代性别比例,并确定确定性偏倚是否是所观察到的雌性后代优势的原因。 。来自巴塞罗那,西班牙和波士顿的家族癌症诊所共收集了145个BRCA1(n = 83)或BRCA2(n = 62)突变的乳腺癌和/或卵巢癌家庭,以及90个无明显突变的家庭。 ,美国。分析了所有(经测试和专心)携带者的家庭和后代中所有出生的性别比。为了最大程度地减少癌症家族史的影响,还对未感染儿童的最新一代突变阳性携带者的后代进行了分析,并与由最近成年后代组成的对照组进行了比较从已知突变的家族中产生了非携带者。在所有组中,女性出生的比例都有统计学意义的较高(BRCA1 59%(95%CI = 57-61%),BRCA2 58%(56-61%)和BRCA阴性59%(56-61%),分别)。在仅限于BRCA1和BRCA2携带者后代的分析中,女性优势仍然存在(分别为61%(57-65%)和62%(58-66%)),两个突变组之间没有差异。相反,当确定性或回忆偏倚最小化时,过量的雌性后代消失,BRCA1为44%(37-52%)和39%(26-53%)。对于BRCA2,这一比例为51%(44-58%)和46%(33-60%)。我们的发现表明,BRCA1或BRCA2突变携带者之间的出生结局没有不对称性。参与基因测试的家庭或他们提供的家族史信息中的确定性偏颇可能是造成先前报道的雌性后代过多的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号